GLP-1 Weight Loss in Wilmington, NC: Why No Local Clinic Will Quote You a Price
Eight Wilmington providers checked and none publish a self-pay GLP-1 price, plus NC Medicaid's Wegovy-first reinstatement and New Hanover County's re-drawn low-income HPSAs.
Wilmington is not a high-prevalence outlier: 31.9% of adults have obesity (CDC PLACES, crude prevalence, BRFSS 2023) 1 against 34.0% statewide for North Carolina 2, roughly two points below the state. The local story is price opacity, not prevalence.
The city has 125,284 residents inside a 480,522-person metro, a median household income of $63,165, and a computed 5.8% uninsured rate, low for the state and consistent with North Carolina's Medicaid expansion taking effect December 1, 2023 3456.
HRSA's HPSA Dashboard (data.hrsa.gov) shows New Hanover County carrying active, DESIGNATED shortage areas across all three HPSA disciplines. A FACILITY-type HPSA at New Hanover Community Health Center (an FQHC, designated 2002, still active) covers Primary Care (score 17), Dental Health (score 25), and Mental Health (score 20). Separately, POPULATION-GROUP (low-income) HPSAs were re-drawn Sept. 2025–Feb. 2026 into two named sub-areas — "New Hanover Wilmington" and "New Hanover Cape Fear" — each newly Designated across Primary Care (scores 11 and 17), Dental Health (scores 17 and 15), and Mental Health (scores 18 and 16); the older county-wide low-income HPSAs they replaced are listed "Proposed For Withdrawal." New Hanover County is NOT rural-designated — this is an access-for-the-underinsured story, not a broad physician-desert story.7
Specialist access
HRSA's HPSA framework has no endocrinology or obesity-medicine shortage category — only primary care, dental, and mental health are designated — so no federal shortage designation applies to specialist access in Wilmington specifically. Local specialist capacity does exist: Wilmington Health (the region's largest independent multispecialty group) runs a dedicated endocrinology department, and Novant Health New Hanover Regional Medical Center has affiliated endocrinologists. Consumer directories disagree sharply on scale — Healthgrades lists ~16 endocrinology/diabetes/metabolism specialists serving Wilmington, WebMD lists ~29 for the same area — a ~2x gap with no stated methodology from either, so treat any specific headcount as unverified. No appointment wait-time data exists in any source.1718
Medicaid coverage note
NC Medicaid reinstated coverage of GLP-1s for weight management effective Dec. 12, 2025, after a coverage pause running roughly early October to Dec. 12, 2025, reverting to the Aug. 1, 2024 prior-authorization criteria. Wegovy, Zepbound, and Saxenda were added back to the Preferred Drug List, with Wegovy as the Preferred Product — beneficiaries must try and fail Wegovy (or document a contraindication) before Zepbound or Saxenda is approved. This applies to the NC Medicaid population only and doesn't touch the self-pay/commercial market Astra's national $68/$118 monthly pricing serves. Separately, NC expanded Medicaid eligibility statewide effective Dec. 1, 2023 — relevant context for the city's relatively low computed uninsured rate.8
NC Medicaid reinstated GLP-1 coverage, with Wegovy first
NC Medicaid reinstated coverage of GLP-1s for weight management effective December 12, 2025, after a pause running roughly from early October to December 12, 2025, reverting to the August 1, 2024 prior-authorization criteria 8. Wegovy, Zepbound, and Saxenda were added back to the Preferred Drug List, with Wegovy as the Preferred Product: beneficiaries must try and fail Wegovy, or document a contraindication, before Zepbound or Saxenda is approved 8.
That applies to the NC Medicaid population only and does not touch the self-pay and commercial market. Separately, North Carolina expanded Medicaid eligibility statewide effective December 1, 2023, useful context for New Hanover County's relatively low computed uninsured rate 58.
What GLP-1 care costs in Wilmington today
Eight physically addressed Wilmington providers were checked directly on their own sites, and not one publishes a self-pay GLP-1 price. Wilmington Weight Loss Clinic, 240 Racine Dr Ste. 202, names semaglutide and tirzepatide programs but states only that its program costs less than three months of the shots, citing a generic market range of $499 to $1,200/month for GLP-1s in general; no number for its own program appears anywhere on the site 9.
Novant Health Weight Management & Wellness, the dominant regional system's Wilmington clinic on Medical Center Drive, discloses no self-pay price and does not name GLP-1s, semaglutide, or tirzepatide at all, listing only generic medical weight management alongside surgical options such as sleeve gastrectomy 10. Achieve Medical Weight Loss at 4130 Oleander Dr, a national franchise location offering a GLP-1 plus lipotropic-injection program, has no pricing page anywhere on its site 11. Wave Aesthetics, Slim Clinic on Military Cutoff Rd, Salt Aesthetics Bar, and BioSymmetry on Racine Dr were checked with the same result 12131415. A Medi-Weightloss listing marketed as Wilmington/Talleyville is Wilmington, Delaware, and is excluded from every local claim here 16. All checked 2026-08-28.
Astra's national price is $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 billed annually. That price is identical in every state Astra serves; there is no city rate.
New Hanover County's shortage is an underinsurance gap, not a physician desert
HRSA's HPSA Dashboard shows New Hanover County carrying active Designated shortage areas in all three disciplines. A facility-type HPSA at New Hanover Community Health Center, an FQHC designated in 2002 and still active, covers Primary Care (score 17), Dental Health (25), and Mental Health (20). Low-income population-group HPSAs were re-drawn between September 2025 and February 2026 into two named sub-areas, New Hanover Wilmington and New Hanover Cape Fear, each newly Designated across Primary Care (scores 11 and 17), Dental Health (17 and 15), and Mental Health (18 and 16); the older countywide low-income HPSAs they replaced are listed Proposed For Withdrawal 7. The county is not rural-designated.
Specialist capacity does exist: Wilmington Health, the region's largest independent multispecialty group, runs a dedicated endocrinology department, and Novant Health New Hanover Regional Medical Center has affiliated endocrinologists 18. Consumer directories disagree sharply on scale, with Healthgrades listing about 16 endocrinology, diabetes, and metabolism specialists serving Wilmington and WebMD listing about 29 for the same area, a roughly twofold gap with no stated methodology from either, so any headcount here is unverified 17. No appointment wait-time data exists in any source, and HRSA has no shortage category for endocrinology or obesity medicine.
Astra publishes its price before the consult and is licensed in all 50 states, so a Wilmington patient can compare a real number against a market that will not quote one. See the North Carolina GLP-1 overview for statewide context.
Astra treats patients in North Carolina through state-licensed physicians.
Local options
Wilmington Weight Loss Clinic — Independent clinic at 240 Racine Dr Ste. 202, Wilmington, NC 28403, naming semaglutide and tirzepatide programs by name. Publishes no clinic-specific price: the site states only that its program "costs less than 3 months of the shots" and cites a generic market range of $499–$1,200/month for GLP-1s generally — no number for its own program appears anywhere on the site. https://wilmingtonweightloss.com/(checked 2026-08-28)
Novant Health Weight Management & Wellness — The region's dominant hospital system's Wilmington clinic (Medical Center Drive, off Carolina Beach Rd/Hwy 421). Discloses no self-pay price anywhere on its site, and does not name GLP-1s, semaglutide, or tirzepatide specifically — its own pages list only generic "medical weight management" among nonsurgical options, alongside surgical procedures like sleeve gastrectomy. https://www.novanthealth.org/locations/clinics/weight-management-wellness/(checked 2026-08-28)
Achieve Medical Weight Loss (Wilmington) — National franchise location at 4130 Oleander Dr, Wilmington, NC 28403, offering a GLP-1 plus lipotropic-injection program. No pricing page exists anywhere on its site — a non-disclosure pattern pronounced enough that third-party trackers have published pieces titled "Achieve Medical Weight Loss Cost: What They Don't List." https://www.amwl.net/(checked 2026-08-28)
Frequently asked questions
How much does Ozempic, Wegovy, or Zepbound cost in Wilmington, NC without insurance?
No local clinic will say. Of eight physically-addressed Wilmington weight-loss providers checked directly on their own sites — independent clinics, med spas, a national franchise, and the region's dominant hospital system — not one publishes a self-pay GLP-1 price; all route to a phone call or consult. The only public number tied to a local clinic is Wilmington Weight Loss Clinic's own cited market range of $499–$1,200/month, offered as context rather than its own price. Astra's price is public and flat everywhere it's licensed: $68/month for semaglutide, $118/month for tirzepatide, on 12-month plans.
Does NC Medicaid cover Wegovy or Zepbound for weight loss in Wilmington?
Yes, as of Dec. 12, 2025. NC Medicaid reinstated GLP-1 coverage for weight management after a pause, with Wegovy as the Preferred Drug List product — beneficiaries must try and fail Wegovy, or document a contraindication, before Zepbound or Saxenda is approved. This applies to NC Medicaid beneficiaries specifically and doesn't change pricing for self-pay or commercially insured patients.
Is Wilmington, NC a health professional shortage area (HPSA)?
For low-income primary care, dental, and mental health, yes — HRSA has active Designated HPSAs covering New Hanover County, anchored by New Hanover Community Health Center (an FQHC) and two newly re-drawn population-group areas covering the county's low-income residents. New Hanover County is not rural-designated, and HRSA has no shortage category for endocrinology or obesity medicine specifically, so this reads as an access gap for underinsured patients, not a general physician shortage.
Is Astra cheaper than weight-loss clinics in Wilmington?
Almost certainly, though it isn't a clean apples-to-apples comparison because no Wilmington clinic checked publishes its own price. The only local reference point — Wilmington Weight Loss Clinic's cited market range of $499–$1,200/month for GLP-1 drugs generally — sits well above Astra's published $68/month semaglutide and $118/month tirzepatide on 12-month plans. Every other local option, independent and hospital-system alike, keeps its number behind a phone call, so Astra's flat published price is the only one a patient can check before booking anything.
What is the adult obesity rate in Wilmington, NC vs. North Carolina overall?
31.9% of Wilmington adults (CDC PLACES, crude prevalence, 2023 BRFSS data) versus 34.0% statewide (CDC BRFSS, 2023) — Wilmington runs about 2 points below the state average, a moderate-prevalence market relative to the rest of North Carolina, not a high-prevalence outlier.